29

Bicalutamide 150 mg in addition to standard care in patients with localized or locally advanced prostate cancer: results from the second analysis of the early prostate cancer program at median followup of 5.4 years

Wirth M, See WA, McLeod D, Iversen P, Morris T, Carrol C

J Urol 2004

Abstract

28

Is the efficacy of hormonal therapy affected by lymph node status? Data from the bicalutamide (Casodex) Early Prostate Cancer Program

Iversen P, Wirth MP, See WA, McLeod DG, Klimberg I, Gleason D, Chodak G, Montie J, Tyrrell C, Wallace DMA, Delare KPJ, Lundmo P,Tammela TLJ, Johansson J-E, Morris T, Carrol K

Urology 2004

Abstract

27

Bicalutamide monotherapy for early stage prostate cancer: an update

Iversen P

J Urol Suppl. 2003

Abstract

26

Immediate treatment with Bicalutamide 150 mg as adjuvant therapy significantly reduces the risk of PSA progression in early prostate cancer

See W, Iversen P, Wirth M, McLeod D, Garside L, Morris T

Eur Urol 2003

SPCG-6

Abstract

25

Bicalutamide 150 mg as adjuvant to radiotherapy significantly increases progression-free survival in early prostate cancer.

Payne H, Tyrrell CJ, See WA, McLeod DG, Wirth MP, Iversen P, Garside L.

Int J Radiat Oncol Biol Phys 2003

Abstract

24

Does prophylactic breast irradiation prevent antiandrogen-induced gynecomastia? Evaluation of 253 patients in the randomized Scandinavian trial SPCG-7/SFUO-3

Widmark A, Fosså SD, Lundmo P, Damber JE, Vaage S, Damber L, Wiklund F, Klepp O

Urology. 2003

SPCG-7/FUO3

Abstract

23

A randomised comparison of bicalutamide (“Casodex”) 150 mg versus placebo as immediate therapy either alone or as adjuvant to standard care for early non-methastatic prostate cancer. First report from the Scandinavian Prostatic Cancer Group Study no. 6

Iversen P, Tammela TLJ, Vaage S, Lukkarinen O, Lodding P, Bull-Njaa T, Viitanen J, Hoisaeter P, Lundmo P, Rasmussen F, Johansson J-E, Persson B-E, Carroll K

European Urology 2002

SPCG-6

Abstract

22

Quality of life after radical prostatectomy or watchful waiting

Steineck G, Helgesen F, Adolfsson J, Dickman PW, Johansson J-E, Norlén BJ, Holmberg L

N Engl J Med. 2002

SPCG-4

Abstract

21

A randomized trial comparing radical prostatectomy with watchful waiting in early prostate cancer

Holmberg L, Bill-Axelson A, Helgesen F, Salo JO, Folmerz P, Häggman M, Andersson S-O, Spångberg A, Busch C, Nordling S, Palmgren J, Adami H-O, Johansson J-E, Norlén BJ

N Engl J Med. 2002

SPCG-4

Abstract

20

Bicalutamide as immediate therapy either alone or as adjuvant to standard care of patients with localized or locally advanced prostate cancer: First analysis of the early prostate cancer program

See WA, Wirth MP, McLeod DG, Iversen P, Klimberg I, Gleason D, Chodak G, Montie J, Tyrrell C, Wallace DMA, Delaere KPJ, Vaage S, Tammela TLJ, Lukkarinen O, Persson B-E, Carroll K, Kolvenbag GJCM

J Urol 2002

Abstract